Company Research Report: CorTec GmbH

Company Overview

• Name: CorTec GmbH

• Mission: To provide solutions for the communication with the nervous system to enable the development of novel and effective therapies and medical devices, improving the life quality of people suffering from neurological diseases.

• Founded: September 2010

• Founders: No specific information is available

• Key People:

• Dr. Martin Schuettler: Chief Technology Officer (CTO)

• Dr. Oliver Baertl: Chief Executive Officer (CEO)

• Headquarters: Freiburg, Germany

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Innovating in implantable neurotechnologies, specifically with products like the CorTec Brain Interchange Platform.

Products

°AirRay Electrodes

• Description: These are electrodes used for interfacing with the central and peripheral nervous systems.

• Key Features:

• Laser-structured technology.

• Various configurations including planar and 3D structures.

• Applications include ECoG, intrafascicular, intrasulcal, and nerve cuff electrodes.

• FDA cleared for cortical applications.

Brain Interchange ONE

• Description: A fully implantable system designed for chronic open- and closed-loop interaction with the nervous system.

• Key Features:

• Wireless functionality.

• Enables recording and stimulation on 32 channels.

• Inductive power and broad-band radio link communication.

Encapsulation Technology

• Description: Provides protective solutions for implant electronics using both hermetic and non-hermetic encapsulations.

• Key Features:

• High channel count implant housings.

• Silicone overmolding for reduced tissue reaction and long-term stability.

Custom Solutions

• Description: CorTec offers customized designs tailored to specific medical device requirements.

Recent Developments

• New Products and Technologies:

• May 23, 2024: FDA approved the Investigational Device Exemption for the closed-loop Brain Interchange implant system, allowing its use in a novel stroke rehabilitation study.

• October 14, 2024: Announced IRB approval from the University of Washington for a feasibility study on stroke rehabilitation using the Brain Interchange system.

• Partnerships:

• Collaborations with the University of Washington School of Medicine and University of California, Los Angeles for clinical studies using the Brain Interchange System.

• NIH funding for rehabilitation studies focusing on upper limb impairment in stroke patients.

• Research and Development:

• Projects supported by several funding bodies including German Federal Ministry of Education and Research and NIH.

• Participation in the Cluster of Excellence BrainLinks-BrainTools at the University of Freiburg.

• Events:

• Participation in events like MD&M Minneapolis 2024, Neurotech Leaders Forum, and COMPAMED 2024, showcasing their latest innovations.

This report compiles the latest available data on CorTec GmbH, highlighting their focus on advancing neurotechnologies and solidifying their presence in the medical device industry with innovative products and strategic partnerships.